Compile Data Set for Download or QSAR
Report error Found 63 Enz. Inhib. hit(s) with all data for entry = 50017876
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187848(5-(2,3-dichlorophenylamino)-3-hydroxy-N-(1-hydroxy...)
Affinity DataIC50: 38nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187817(5-(2-chloro-4-iodophenylamino)-3-hydroxy-N-isoprop...)
Affinity DataIC50: 42nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187818(5-(2-chloro-4-iodophenylamino)-3-hydroxy-N-(1-hydr...)
Affinity DataIC50: 44nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187841(3-hydroxy-5-(4-iodo-2-methylphenylamino)-N-isoprop...)
Affinity DataIC50: 62nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187801(5-(2-chloro-4-(trifluoromethyl)phenylamino)-3-hydr...)
Affinity DataIC50: 68nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187855(3-hydroxy-N-(1-hydroxypropan-2-yl)-5-(4-iodo-2-met...)
Affinity DataIC50: 73nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187845(5-(2-chloro-4-(trifluoromethyl)phenylamino)-3-hydr...)
Affinity DataIC50: 86nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187812(5-(2,3-dichlorophenylamino)-3-hydroxy-N-isopropyli...)
Affinity DataIC50: 220nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187815(5-(2,4-dichlorophenylamino)-3-hydroxyisothiazole-4...)
Affinity DataIC50: 250nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187857(methyl 4-(4-(N-(cyclohexylmethyl)carbamimidoyl)-3-...)
Affinity DataIC50: 350nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187852(N-(cyclohexylmethyl)-5-(2,4-dichlorophenylamino)-3...)
Affinity DataIC50: 410nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187829(5-(4-chlorophenylamino)-3-hydroxyisothiazole-4-car...)
Affinity DataIC50: 410nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187830(5-(4-chlorophenylamino)-N-(cyclohexylmethyl)-3-hyd...)
Affinity DataIC50: 420nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187850(5-(4-bromophenylamino)-N-(cyclohexylmethyl)-3-hydr...)
Affinity DataIC50: 430nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187838(5-(3-chlorophenylamino)-N-(cyclohexylmethyl)-3-hyd...)
Affinity DataIC50: 500nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187813(5-(3-bromophenylamino)-N-(cyclohexylmethyl)-3-hydr...)
Affinity DataIC50: 500nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187831(5-(3-bromophenylamino)-3-hydroxyisothiazole-4-carb...)
Affinity DataIC50: 500nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187821(3-hydroxy-5-4-iodophenylamino)-N-isopropylisothiaz...)
Affinity DataIC50: 510nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187827(5-(2,5-dichlorophenylamino)-3-hydroxyisothiazole-4...)
Affinity DataIC50: 620nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187835(5-(4-chloro-3-(trifluoromethyl)phenylamino)-3-hydr...)
Affinity DataIC50: 650nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187856(N-(cyclohexylmethyl)-3-hydroxy-5-(2-methoxy-4-nitr...)
Affinity DataIC50: 670nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187832(N-(cyclohexylmethyl)-5-(2,4-dimethylphenylamino)-3...)
Affinity DataIC50: 690nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187858(N-(cyclohexylmethyl)-5-(3,5-dichlorophenylamino)-3...)
Affinity DataIC50: 790nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187807(5-(3,5-dichlorophenylamino)-3-hydroxyisothiazole-4...)
Affinity DataIC50: 800nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187822(5-(p-toluidino)-N-(cyclohexylmethyl)-3-hydroxyisot...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187822(5-(p-toluidino)-N-(cyclohexylmethyl)-3-hydroxyisot...)
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187823(N-(cyclohexylmethyl)-3-hydroxy-5-(pyridin-3-ylamin...)
Affinity DataIC50: 1.23E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187805(5-(4-chloro-3-nitrophenylamino)-N-(cyclohexylmethy...)
Affinity DataIC50: 1.39E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187862(N-(cyclohexylmethyl)-3-hydroxy-5-(2-methoxyphenyla...)
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187820(3-hydroxy-N-(1-hydroxypropan-2-yl)-5-(4-iodophenyl...)
Affinity DataIC50: 1.44E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187860(N-(cyclohexylmethyl)-5-(2-fluorophenylamino)-3-hyd...)
Affinity DataIC50: 1.45E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187802(5-(p-toluidino)-N-ethyl-3-hydroxyisothiazole-4-car...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187859(4-(2,3-dihydro-1H-tetrazol-5-yl)-5-(3,5-dimethoxyp...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187853(5-(p-toluidino)-N,3-dihydroxyisothiazole-4-carboxa...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187809(5-(p-toluidino)-3-hydroxy-N-(piperidin-1-yl)isothi...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187806(3-hydroxy-5-(3-methoxyphenylamino)isothiazole-4-ca...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187824(methyl 3-(4-cyano-3-hydroxyisothiazol-5-ylamino)be...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187861(5-(butylamino)-3-hydroxyisothiazole-4-carbonitrile...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187826(3-hydroxy-5-(1-phenylethylamino)isothiazole-4-carb...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187825(4-cyano-5-phenylamino-N-methyl-3-isothiazolone | C...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187851(5-(4-hydroxyphenethylamino)-3-hydroxyisothiazole-4...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187803(3-hydroxy-5-(isopropylamino)isothiazole-4-carbonit...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187828(3-hydroxy-5-(2-methoxyphenylamino)isothiazole-4-ca...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187854(3-hydroxy-5-(4-methoxyphenylamino)isothiazole-4-ca...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187819(5-(p-toluidino)-3-hydroxyisothiazole-4-carbonitril...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187846(3-hydroxy-5-(2-(thiophen-2-yl)ethylamino)isothiazo...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187816(5-(cyclohexylmethylamino)-3-hydroxyisothiazole-4-c...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187804(3-hydroxy-5-(4-isopropylphenylthio)isothiazole-4-c...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187814(3-hydroxy-5-(4-phenoxyphenoxy)isothiazole-4-carbon...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetDual specificity mitogen-activated protein kinase kinase 1(Human)
Valeant Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50187834(5-(o-toluidino)-3-hydroxyisothiazole-4-carbonitril...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of MEK1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: